F&P Healthcare changes up board
By HME News Staff
Updated 10:35 AM CDT, Mon July 24, 2023
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has announced that Donal O’Dwyer will retire as director of the company effective Dec. 31, 2023. The company has also announced that it has appointed Graham McLean to the board as a non-executive director effective Oct. 1, 2023. “With Donal preparing to step away, we are very pleased to have secured Graham as a director,” said Scott St John, board chair. “Similar to Donal, Graham has carved out a successful global career in the medical device field and we are confident he will be an impactful addition to the board.” McLean, an Australian resident, is currently director and CEO of CleanSpeaceHoldings and chair of Universal Biosensors, two ASX-listed health care companies. He previously spent 16 years as an executive at Stryker Corp., most recently as president of the Asia Pacific region. McLean will also serve as a member of the F&P’s Audit and Risk Committee.
Comments